Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

137511 Press Releases
DateTitleCompany
30 Sep 16 Half-Year Results 2016 and Update on Operational Development Published by
GlobeNewswire
30 Sep 16 US CareNet Announces HC360 Technologies US CareNet,
Published by
PR Newswire
30 Sep 16 Does Shakeology Really Work? DIR Inc.,
Published by
PR Newswire
30 Sep 16 Number of Shares and Votes in Orexo Orexo,
Published by
Business Wire
30 Sep 16 Global Pharmaceutical Contract Manufacturing Market - Trends and Forecasts (2015 - 2020) - Research and Markets Research and Markets,
Published by
Business Wire
30 Sep 16 HIV Forecast in 8 Major Markets Report 2016-2026 - Analysis, Technologies & Forecasts - Research and Markets Research and Markets,
Published by
Business Wire
30 Sep 16 BioNJ Announces Inaugural Patient Advocacy Summit for November 4 BioNJ,
Published by
Business Wire
30 Sep 16 Global Thalassemia Therapeutics Report 2016 - Pipeline Review of 22 Companies & 36 Drug Profiles - Research and Markets Research and Markets,
Published by
Business Wire
30 Sep 16 Polycystic Ovarian Syndrome Therapeutics Report 2016 - Pipeline Review of 7 Companies & 9 Drug Profiles - Research and Markets Research and Markets,
Published by
Business Wire
30 Sep 16 Trichomonas Vaginitis Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Vendors: Bayer, AmVac, Lumavita - Research and Markets Research and Markets,
Published by
Business Wire
30 Sep 16 NeuroDerm Provides Updates on ND0612 Long-Term Safety Trial and Submission of Marketing Applications NeuroDerm ,
Published by
PharmiWeb.com
30 Sep 16 Now Enrolling: Global Phase 3 Clinical Trial to Evaluate Potential First-Line Use of Lenvatinib in Combination with Pembrolizumab or Everolimus for Patients with Advanced Renal Cell Carcinoma Eisai ,
Published by
PharmiWeb.com
30 Sep 16 Enanta Pharmaceuticals Initiates Phase 1 Clinical Study of EDP-305, its Lead FXR Agonist for the Treatment of Non-alcoholic Steatohepatitis (NASH) Enanta Pharmaceuticals ,
Published by
PharmiWeb.com
30 Sep 16 Karyopharm Publishes Preclinical Data in Nature Demonstrating Selinexor’s Potential in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC) Karyopharm ,
Published by
PharmiWeb.com
30 Sep 16 MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis MorphoSys ,
Published by
PharmiWeb.com
30 Sep 16 Researchers reveal how dangerous intestinal toxin enters cells Boston Children's Hospital ,
Published by
PharmiWeb.com
30 Sep 16 Two New Studies from the Mayo Clinic and Lankenau Medical Center Presented at Heart Failure Society of America 2016 Highlight Unique Ability of BVA to Identify High Risk at Discharge in Hospitalized Heart Failure Patients Daxor Corporation,
Published by
PharmiWeb.com
30 Sep 16 MYOS RENS Announces Publication of Its Fortetropin(R) Human Clinical Trial Manuscript MYOS RENS ,
Published by
PharmiWeb.com
30 Sep 16 New data for Halaven® (eribulin), Lenvima® (lenvatinib) and Kisplyx® (lenvatinib) demonstrate continued strength of Eisai oncology portfolio at ESMO 2016 Eisai ,
Published by
PharmiWeb.com
30 Sep 16 Cellular Dynamics International Launches Opsis Therapeutics to Develop Cell Therapies for Treatment of Retinal Diseases Cellular Dynamics International ,
Published by
PharmiWeb.com
30 Sep 16 Abide Therapeutics Announces Celgene Option Exercise to Develop ABX-1431, an Investigational Endocannabinoid System Modulator for Patients with Neurological Diseases Abide Therapeutics ,
Published by
PharmiWeb.com
30 Sep 16 U.S. Food and Drug Administration Approves ORKAMBI® (lumacaftor/ivacaftor) for Use in Children with Cystic Fibrosis Ages 6 through 11 who have Two Copies of the F508del Mutation Cellectar Biosciences ,
Published by
PharmiWeb.com
30 Sep 16 Cellectar Biosciences Announces New Positive Data from Phase I Clinical Study of CLR 131 in Multiple Myeloma Cellectar Biosciences ,
Published by
PharmiWeb.com
30 Sep 16 U.S. FDA Accepts for Priority Review Supplemental New Drug Application for the Use of ORKAMBI® (lumacaftor/ivacaftor) in Children with Cystic Fibrosis Ages 6 to 11 who have Two Copies of the F508del Mutation Cellectar Biosciences ,
Published by
PharmiWeb.com
30 Sep 16 Rennova Health, Inc. Signs Definitive Agreement to Acquire Pharmacogenetic Laboratory, Genomas Rennova ,
Published by
PharmiWeb.com
30 Sep 16 Bayer and DelSiTech Partner to Develop Innovative Drug Delivery Technology for Ophthalmology Bayer ,
Published by
PharmiWeb.com
30 Sep 16 Charles River Laboratories Acquires Agilux Laboratories, Inc. Charles River Laboratories ,
Published by
PharmiWeb.com
30 Sep 16 Evotec receives further important pre-clinical milestone in endometriosis alliance with Bayer Evotec ,
Published by
PharmiWeb.com
30 Sep 16 Cytokinetics Announces Early Termination of Hart-Scott-Rodino Waiting Period for Expanded Collaboration With Astellas Cytokinetics ,
Published by
PharmiWeb.com
30 Sep 16 PathoQuest Announces Partnership with Charles River Laboratories PathoQuest ,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.